National Bank of Canada
DRUG

National Bank of Canada’s Bright Minds Biosciences DRUG Stock Holding History

National Bank of Canada’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-92
Closed -$3.31K – 2922
2024
Q4 		$3.31K Sell
92
-4,867
-98% -$171K ﹤0.01% 2508
2024
Q3 		$5.8K Sell
4,959
-41
-0.8% -$46 ﹤0.01% 2178
2024
Q2 		$5.23K Hold
5,000
– – ﹤0.01% 2251
2024
Q1 		$5.25K Buy
+5,000
New +$8.76K ﹤0.01% 2298

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

National Bank of Canada's DRUG Position: Q1 2025 in Review

National Bank of Canada sold out of Bright Minds Biosciences (DRUG) in Q1 2025, closing a stake of 92 shares — an estimated $3.31K sold.

National Bank of Canada first reported a position in DRUG in Q1 2024 and held it in 4 quarters. The position peaked at $5.8K in Q3 2024. 34 funds tracked by Wall St. Rank hold DRUG as of Q1 2025.

  • National Bank of Canada reported no remaining Bright Minds Biosciences position as of Q1 2025 after selling out during the quarter.
  • National Bank of Canada sold 92 Bright Minds Biosciences shares in Q1 2025, an estimated $3.31K.
  • National Bank of Canada first reported a position in Bright Minds Biosciences in Q1 2024 and held it in 4 quarters.
  • National Bank of Canada's Bright Minds Biosciences position peaked at $5.8K in Q3 2024.
  • 34 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2025.

Based on National Bank of Canada's 13F filing for Q1 2025, filed 12 May 2025.